SB 1344: Federal Drug Pricing Program
GENERAL BILL by Wright
Federal Drug Pricing Program; Defining the terms “340B entity” and “health insurer”; prohibiting health insurers, pharmacy benefit managers, or third parties from reimbursing 340B entities at certain rates or imposing specified adjustments, exclusions, or claim requirements upon such entities, etc.
Effective Date: 7/1/2022
Last Action: 3/14/2022 Senate - Died in Banking and Insurance
Bill Text: Web Page | PDF
Last Action: 3/14/2022 Senate - Died in Banking and Insurance
Bill Text: Web Page | PDF
Senate Committee References:
- Banking and Insurance (BI)
- Health Policy (HP)
- Rules (RC)
-
Bill History
Date Chamber Action 12/21/2021 Senate • Filed
1/12/2022 Senate • Referred to Banking and Insurance; Health Policy; Rules -SJ 120
1/18/2022 Senate • Introduced -SJ 120
3/12/2022 Senate • Indefinitely postponed and withdrawn from consideration
3/14/2022 Senate • Died in Banking and Insurance
-
SB 1344, Original Filed Version (Current Bill Version) Posted 12/21/2021 at 10:15 AM
Bill Text: Web Page | PDF Analyses: None Citations - Statutes (1)
Citation Catchline Location in Bill Location In Bill Help 627.4216 Page 1 (pdf)